DYSFUNCTIONAL UTERINE BLEEDING Ralph Boling, DO, FACOG, FACOOG - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

DYSFUNCTIONAL UTERINE BLEEDING Ralph Boling, DO, FACOG, FACOOG

Description:

Associated with anovulation, which results in unopposed estrogen stimulation to the endometrium ... Chronic anovulation can lead to further abnormal bleeding episodes ... – PowerPoint PPT presentation

Number of Views:269
Avg rating:3.0/5.0
Slides: 23
Provided by: systema207
Category:

less

Transcript and Presenter's Notes

Title: DYSFUNCTIONAL UTERINE BLEEDING Ralph Boling, DO, FACOG, FACOOG


1
DYSFUNCTIONAL UTERINE BLEEDINGRalph Boling, DO,
FACOG, FACOOG
2
Definition
  • Abnormal uterine bleeding in the absence of
    uterine pathology or medical illness.
  • Associated with anovulation, which results in
    unopposed estrogen stimulation to the endometrium

3
Menstrual Cycle
  • The normal menstrual cycle occurs at regular
    intervals of 24-35 days.
  • Average duration of flow is 4-6 days can be
    as few as 2 days and as many as 7 days.
  • Flow of longer than 7 days deserves evaluation.
  • Average blood loss during one menses is about 30
    mL

4
Changes During Menstrual Cycle
  • Normal ovulatory endometrial changes throughout
    the menstrual cycle can be divided into five
    phases a) menstrual endometrium phase b)
    proliferative phase c) secretory phase d)
    implantation phase e) exfoliative phase or
    endometrial breakdown

5
Types of Bleeding
  • Menorrhagia - excessive and prolonged uterine
    bleeding at regular intervals
  • Metrorrhagia - irregular, intramenstrual bleeding
  • Menometrorrhagia - heavy, prolonged, irregular
    bleeding at frequent, irregular intervals
  • Polymenorrhea - frequent, regular episodes of
    uterine bleeding at intervals of less than 21
    days
  • Oligomenorrhea - irregular bleeding occurring at
    prolonged intervals of more than 35 days
  • Amenorrhea - absence of uterine bleeding

6
Diagnosis
  • Most cases of anovulatory bleeding are the result
    of estrogen withdrawal or estrogen breakthrough
    bleeding
  • High sustained levels of estrogen and heavy
    bleeding are associated with polycystic ovaries
  • When there is unopposed estrogen stimulation to
    the endometrium and no periodic desquamation, the
    endometrium reaches abnormal heights and lacks
    structural support

7
Diagnosis (cont.)
  • The first and most important step in the
    diagnostic process is obtaining a physical
    examination and a detailed clinical history with
    an in-depth understanding of the patient's
    menstrual characteristics

8
Diagnosis (cont.)
  • Blood tests may include a) a complete blood
    count b) quantitative human chorionic
    gonadotropin c) thyroid function tests d)
    prolactin e) clotting studies (prothrombin time,
    activated partial thromboplastin time,
    antithrombin III, protein C, protein S,
    fibrinogen, plasminogen) f) liver and renal
    function tests
  • g) glucose and insulin evaluation

9
Diagnosis (cont.)
  • Abnormalities of the uterus can be detected
    by a) abdominal or transvaginal ultrasound b)
    hysterosalpingography
  • A sampling of the endometrial cavity should be
    considered in all cases of abnormal uterine
    bleeding

10
(No Transcript)
11
(No Transcript)
12
(No Transcript)
13
Diagnosis (cont.)
  • Although not mandatory in the perimenarchal
    patient, it is mandatory in the perimenopausal
    patient to exclude a premalignant or malignant
    condition
  • It is not the age of the patient that is critical
    when considering an endometrial sampling but the
    duration of unopposed estrogen exposure

14
Progestational Agents
  • Once pathology has effectively been ruled out,
    progestin therapy can restore synchrony to the
    endometrial lining and return the menstrual
    patterns to normal

15
ESTROGEN
  • If bleeding has been prolonged and there is
    insufficient tissue for progestin action,
    estrogen therapy is indicated to cause rapid
    growth of the endometrium.

16
Low-Dose Oral Contraceptives
  • In young anovulatory women in whom there is
    prolonged unopposed endogenous estrogen
    low-dose (less than 50 mg estrogen) oral
    contraceptive

17
Antiprostaglandins
  • Nonsteroidal anti-inflammatory drugs inhibit the
    action of cyclo-oxygenase, and therefore a
    decrease occurs in the various members of the
    prostaglandin family
  • a complete understanding of the mechanism of
    action of nonsteroidal anti-inflammatory drugs is
    unknown

18
Dilation and Curettage
  • Appropriate in women with dysfunctional bleeding
    in whom medical management has been unsuccessful

19
Hysterectomy
  • Hysterectomy a) on occasion is the proper
    treatment for abnormal uterine bleeding b)
    appropriate in extreme cases, such as
    failed medical management or endometrial
    hyperplasia with atypia
  • Endometrial Ablation When medical therapy has
    been unsuccessful, endometrial ablation is
    an alternative therapy

20
How it works
GYNECARE THERMACHOICEUterine Balloon Therapy
System
  • Catheter with heater at tip enclosed in a balloon
  • Balloon catheter inserted through cervix into
    uterus
  • Balloon filled with sterile fluid
  • Expands to fit uterus size, shape
  • Fluid in balloon is heated and circulated during
    8 minute treatment cycle
  • Uterine lining is destroyed by heat
  • Fluid and catheter removed nothing stays in
    uterus
  • Uterine lining will slough off like a period in
    the next 7-10 days

21
Follow-up Treatment
  • After successful treatment of acute episode of
    anovulatory uterine bleeding, patient must be
    followed.
  • Chronic anovulation can lead to further abnormal
    bleeding episodes more importantly, chronic
    unopposed estrogen stimulation to the
    endometrium can lead to atypical tissue
    changes
  • Becomes extremely important for patients to
    undergo periodic progestational withdrawal
    bleeding

22
Medication
  • Ovulating women with menorrhagia can have their
    bleeding controlled with a) nonsteroidal
    anti-inflammatory agents b) progestin
    administered daily for 7 days preceding
    menses c) oral contraceptives given in the
    routine manner
Write a Comment
User Comments (0)
About PowerShow.com